China
China admits its coronavirus response had “shortcomings”
February 4, 2020Manufacturing and Production China, MERS, Sars, Wuhan, china coronavirus, coronavirus, wuihan coronavirus
In a rare move, China’s leadership has admitted “shortcomings” in the way it has handled the outbreak of the deadly …
Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis
January 23, 2020Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …
China approves Roche cancer drug Kadcyla
January 22, 2020Business Services China, Roche, breast cancer, cancer treatment, oncology
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …
WHO officials say Wuhan viral pneumonia outbreak can be passed from person to person
January 20, 2020Sales and Marketing China, Sars, Viral pneumonia, WHO, World Health Organisation, Wuhan Outbreak
The viral pneumonia outbreak that began in Wuhan China can spread between person to person, according to health experts at …
China’s viral pneumonia spreads to Japan
January 17, 2020Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia
A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …
US-China trade deal sees changes on drug patents
January 16, 2020Business Services China, Chinese Drug Patents, Trade Deal, US Drug Patents, US-China Trade Deal
The US and China signed the first part of a broader trade pact that included setting up a system to …
Chinese coronavirus found in Thailand
January 14, 2020Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand
The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …
China approves first homegrown HPV vaccine
January 8, 2020Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines
Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out
January 6, 2020Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia
A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …
AstraZeneca’s drug Lokelma approved in China
January 6, 2020Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
AstraZeneca’s triple combination therapy for patients with COPD approved in China
December 23, 2019Sales and Marketing AstraZeneca, COPD, China, respiration
AstraZeneca has announced that budesonide-glycopyrroniunm-formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease …
Drugmakers cut prices by 61% to get on Chinese reimbursement list
November 28, 2019Manufacturing and Production AstraZeneca, China, China National Reimbursement Scheme, Novartis, Roche Holding
AstraZeneca and Roche Holding are among a number of drugmakers to cut their prices in order to get on China’s …
AstraZeneca reveals three-pronged “large-scale” R&D initiatives in China
November 7, 2019Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China
AstraZeneca has doubled down on its commitment to the Chinese region with the announcement of three “large-scale initiatives” in the …
China green lights first novel Alzheimer’s therapy since 2003
November 4, 2019Sales and Marketing Alzheimer's, China, Green Valley, Oligomannate, pharma
Shanghai Green Valley Pharmaceuticals has announced that its therapy Oligomannate (GV-971) has secured marketing approval from China’s National Medical Products Administration (NMPA) …
Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region
November 1, 2019Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma
Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …
